Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jan;98(1):19-24.
doi: 10.1113/expphysiol.2011.063321. Epub 2012 Jul 30.

Nuclear factor-κB signalling and transcriptional regulation in skeletal muscle atrophy

Affiliations
Review

Nuclear factor-κB signalling and transcriptional regulation in skeletal muscle atrophy

Robert W Jackman et al. Exp Physiol. 2013 Jan.

Abstract

The nuclear factor-κB (NF-κB) signalling pathway is a necessary component of adult skeletal muscle atrophy resulting from systemic illnesses or disuse. Studies showing a role for the NF-κB pathway in muscle disuse include unloading, denervation and immobilization, and studies showing a role for NF-κB in systemic illnesses include cancer, chronic heart failure and acute septic lung injury. Muscle atrophy due to most of these triggers is associated with activation of NF-κB transcriptional activity. With the exception of muscle unloading, however, there is a paucity of data on the NF-κB transcription factors that regulate muscle atrophy, and little is known about which genes are targeted by NF-κB transcription factors during atrophy. Interestingly, in some cases it appears that the amelioration of muscle atrophy by genetic inhibition of NF-κB signalling proteins is due to effects that are independent of the downstream NF-κB transcription factors. These questions are prime areas for investigation if we are to understand a key component of muscle wasting in adult skeletal muscle.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic diagram showing NF-κB signaling and transcription factors involved in muscle atrophy due to illness or to disuse. NF-κB signaling proteins are involved in the signal transduction for atrophy from the myofiber membrane and/or external milieu to activate NF-κB transcription factors which then translocate to the nucleus and bind to NF-κB responsive elements (RE) and induce atrophy gene expression. Unloading atrophy seems to involve, IKKα and IKKβ, plus a non-classical complex involving p50 and Bcl-3. NF-κB signaling proteins are red. Transcription factors p65, p50, and Bcl-3 are green, yellow, and blue, respectively.
Figure 2
Figure 2
Diagram showing the non-NF-κB functions of IKKα (Left panel) and IKKβ (Right panel). The two centrally depicted kinases act on a variety of substrates shown by either an arrow (substrate activated by kinase) or a “T” bar (substrate inhibited by kinase). The cellular processes affected are highlighted in an oval; yellow backgrounds are processes that are induced and blue backgrounds are processes that are inhibited by the kinase activity. Also noted are cases in where the kinase has activity inside the nucleus. The references for data in this figure are noted in the text. As can be surmised, there are several opportunities for each kinase to produce effects on muscle cell metabolism that may be independent of NF-κB transcriptional activity.

References

    1. Acharyya S, Butchbach ME, Sahenk Z, Wang H, Saji M, Carathers M, Ringel MD, Skipworth RJ, Fearon KC, Hollingsworth MA, Muscarella P, Burghes AH, Rafael-Fortney JA, Guttridge DC. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell. 2005;8(5):421–432. - PubMed
    1. Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, Guttridge DC. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest. 2004;114(3):370–378. - PMC - PubMed
    1. Adams V, Spate U, Krankel N, Schulze PC, Linke A, Schuler G, Hambrecht R. Nuclear factor-kappa B activation in skeletal muscle of patients with chronic heart failure: correlation with the expression of inducible nitric oxide synthase. Eur J Cardiovasc Prev Rehabil. 2003;10(4):273–277. - PubMed
    1. Bakkar N, Guttridge DC. NF-kappaB signaling: a tale of two pathways in skeletal myogenesis. Physiol Rev. 2010;90(2):495–511. - PubMed
    1. Bonetto A, Aydogdu T, Jin X, Zhang Z, Zhan R, Puzis L, Koniaris LG, Zimmers TA. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab. 2012 - PMC - PubMed

Publication types